Basic Information
ID: ALA4605537
Type: Binding
Description: Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assay
Format: BAO_0000219
Organism: Homo sapiens
Cell type: DLD-1
Target: Solute carrier family 2, facilitated glucose transporter member 3(ALA5215)
Document: ALA4602704
Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4605537
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 496.42 | 4.17 | 4.17 |
| 551.70 | 5.48 | 5.48 |
| 470.53 | 4.21 | 4.21 |
| 523.64 | 4.70 | 4.70 |
| 497.60 | 4.22 | 4.22 |
| 496.57 | 4.75 | 4.75 |
| 567.69 | 4.72 | 4.72 |
| 497.60 | 4.17 | 4.17 |
| 512.61 | 5.03 | 5.03 |
| 482.54 | 4.31 | 4.31 |
| 509.61 | 4.36 | 4.36 |
| 510.48 | 4.36 | 4.36 |
| 525.66 | 4.95 | 4.95 |
| 511.63 | 4.61 | 4.61 |
| 483.58 | 3.83 | 3.83 |
| 511.63 | 4.42 | 4.42 |
| 509.61 | 4.31 | 4.31 |
| 482.54 | 4.36 | 4.36 |
| 511.63 | 4.56 | 4.56 |
| 555.68 | 4.58 | 4.58 |
| 551.70 | 5.48 | 5.48 |
| 525.66 | 4.95 | 4.95 |
| 525.66 | 4.95 | 4.95 |
| 569.71 | 4.96 | 4.96 |
| 537.67 | 5.09 | 5.09 |
| 535.65 | 4.85 | 4.85 |
| 523.64 | 4.70 | 4.70 |
| 498.59 | 4.99 | 4.99 |
| 484.56 | 4.55 | 4.55 |
| 498.59 | 4.64 | 4.64 |
| 549.68 | 5.24 | 5.24 |
| 525.66 | 4.95 | 4.95 |
| 537.67 | 5.09 | 5.09 |
| 470.53 | 4.21 | 4.21 |
| 539.68 | 5.34 | 5.34 |
| 468.52 | 3.96 | 3.96 |
| 539.68 | 5.19 | 5.19 |
| 557.67 | 5.29 | 5.29 |
| 511.63 | 4.56 | 4.56 |
| 504.55 | 5.33 | 5.33 |